1. Introduction {#sec1-nutrients-11-02842}
===============

Human milk is the ideal source of nutrients for an infant. It is biologically tailored to provide a variety of nutrients, bioactive compounds, and immunological factors, which are crucial for growth and optimal development \[[@B1-nutrients-11-02842]\]. Human milk lipids constitute the largest fraction of the total energy intake during infancy, providing an average of 44% energy supply \[[@B2-nutrients-11-02842]\]. Thus, the composition of fatty acids supplied through human milk is of great interest because these provide a standard for defining adequate nutrient intakes of infants \[[@B3-nutrients-11-02842]\].

Fatty acids in human milk are derived from mobilization of the mother's endogenous stores, from synthesis in the liver or breast tissue, and from the mother's diet \[[@B4-nutrients-11-02842]\]. Maternal gestational duration, age, stage of lactation, diet, and long-term food habits were shown to be associated with the fatty acid composition of human milk \[[@B5-nutrients-11-02842],[@B6-nutrients-11-02842]\]. Thus, fatty acid concentrations in human milk will also vary depending on accessibility to food in a specific region \[[@B7-nutrients-11-02842]\]. Several studies have reported on the fatty acid composition of human milk in Germany \[[@B8-nutrients-11-02842],[@B9-nutrients-11-02842],[@B10-nutrients-11-02842]\] and other parts of Europe and the world \[[@B7-nutrients-11-02842],[@B11-nutrients-11-02842],[@B12-nutrients-11-02842]\]. However, information on changes in fatty acid composition of human milk as lactation progresses remains controversial. Very few \[[@B11-nutrients-11-02842],[@B12-nutrients-11-02842],[@B13-nutrients-11-02842]\] studies have reported changes in human milk fatty acid composition up to 12 months of lactation. Thus, the important practical question of whether human milk can provide a constant supply of fatty acids for infants even as lactation progresses remains.

It is plausible that the results from human milk fatty acid profiling are controversial because of differences in (1) population characteristics including lifestyle factors, (2) timing of milk sampling post-delivery including colostrum, transitional milk, and mature milk across lactation, (3) statistical methodologies neglecting the compositional nature of the data, and (4) sample sizes. Regarding the compositional nature, fatty acids are often reported individually as a relative measure of the percentage/weight of total fatty acids. However, an increase in the percentage of one fatty acid must result in decreases in the relative percentage of one or more other fatty acids, even when their absolute concentrations remain unchanged \[[@B14-nutrients-11-02842],[@B15-nutrients-11-02842],[@B16-nutrients-11-02842]\]. Thus, no individual component should be interpreted isolated from the others.

Considering this, we investigated the fatty acid composition of human milk at three time points during lactation and its change over time in the Ulm SPATZ Health Study. To overcome the constant sum constraint, we applied centered log-ratio transformation (clr) and used principal component analysis (PCA) to identify groups of fatty acids that are correlated. These fatty acid groups could potentially be more relevant in fatty acid profiling and assessing the effect of time and biological changes in human milk compared to using the traditional groups that are based on chemical structure.

2. Materials and Methods {#sec2-nutrients-11-02842}
========================

2.1. Study Design and Population {#sec2dot1-nutrients-11-02842}
--------------------------------

The Ulm SPATZ Health Study is an ongoing birth cohort study in which a total of 1006 newborns and their 970 mothers were recruited from the general population consecutively, during their hospital stay soon after delivery in the University Medical Center Ulm, Southern Germany, between April 2012 and May 2013 \[[@B17-nutrients-11-02842]\]. Mothers were excluded if they had inadequate German language skills, outpatient childbirth, maternal age \<18 years, postpartum transfer of mother or child to an intensive care unit, or stillbirth. Participation in the study was completely voluntary and informed consent was obtained. Ethical approval was obtained from the Ethics board of Ulm University (No. 311/11).

2.2. Data Collection and Measurements {#sec2dot2-nutrients-11-02842}
-------------------------------------

Demographic, lifestyle, and birth-related data including child gender, delivery mode, birth season, birthweight, maternal age, education, parity, pre-pregnancy body mass index (BMI calculated as (mass(kg)/height(m)^2^)), and smoking status (within 1 year prior to delivery) were collected by self-administered questionnaire. Additional information was assessed from electronic hospital charts and from routine screening examinations during pregnancy. Smoking status and alcohol consumption were assessed and defined as previously explained \[[@B17-nutrients-11-02842]\]. Human milk samples were collected at approximately 6 weeks, 6 months, and 12 months post-delivery. Mothers were instructed to manually express or pump breast milk between 09:00 h and 12:00 h, after breakfast and before lunch, but at least one hour after the last feeding. In some cases, trained study nurses helped mothers with expressing. Mothers stored the milk in the fridge until study nurses collected it from their homes and delivered it refrigerated to the study center. Additional data were collected at 6 weeks, 6 months, and 12 months post-delivery by telephone interview or postal self-administered questionnaires. Yearly follow-ups of the whole study population are still ongoing.

2.3. Fatty Acid Analysis {#sec2dot3-nutrients-11-02842}
------------------------

Human milk samples were stored at −80 °C until analysis of fatty acids between 2015 and 2018 by high-resolution capillary gas-liquid chromatography by using the method of Bligh and Dyer \[[@B18-nutrients-11-02842]\] and Beermann et al. \[[@B19-nutrients-11-02842]\]. The lipid content was analyzed using the method outlined by Lucas et al. \[[@B20-nutrients-11-02842]\] and Jones et al. \[[@B21-nutrients-11-02842]\]. Data are reported for 45 fatty acids which include saturated fatty acids (SFAs), monounsaturated fatty acids (MUFAs), trans-fatty acids (TFAs), branched-chain fatty acids (BFAs), and polyunsaturated fatty acids (PUFAs). Peak identification of SFAs, MUFAs, TFAs, and both n-3 and n-6 PUFA methyl esters were verified and calibrated by comparison with authentic standards (NuChek Prep; Elysian, MN, USA: GLC-463, GLC-473, GLC-642, GLC-643, GLC-674, and Sigma-Aldrich Ltd., St. Louis, MO, USA: Supelco PUFA3). The standard mix of BFA methyl esters was originally from Danone Nutricia Research, Utrecht, the Netherlands. Fatty acid concentrations were recorded as %weight of total fatty acids.

2.4. Statistical Analysis {#sec2dot4-nutrients-11-02842}
-------------------------

Clr transformations were applied to fatty acid data to account for compositionality. Clr was calculated as the natural log of the quotient of the individual fatty acid concentration over the geometric mean of all fatty acid concentrations within a sample \[[@B22-nutrients-11-02842]\]. The geometric mean was used as the denominator as it is a meaningful measure of central tendency for variables with skewed distributions. Principal component analysis (PCA) was used to evaluate correlations between fatty acid prior to generating compositional biplots. Fatty acid groups/clusters were selected based on collinear links of a sub-composition showing a one-dimensional pattern in the compositional biplots for 12 months human milk samples. These fatty acid groups/clusters were calculated by adding the individual crude fatty acid concentrations, after which this sum was clr transformed for inclusion into the analysis models. A general linear model was used to assess the impact of maternal pre-pregnancy BMI, change in weight status between pregnancy and at 6 weeks, age, education, occupation, parity, delivery mode, and gestational age on individual human milk fatty acids. Maternal age was included because of its close association with maternal education, less exposure to cigarette smoking, and (prolonged) breastfeeding \[[@B17-nutrients-11-02842]\], thus potentially being an indicator of aspects of life style that might influence human milk fatty acid composition. Additionally, education and occupation were used as proxies for socio-economic status. A general linear model based repeated measure analysis was used to evaluate changes in human milk fatty acid constituents during lactation, adjusting for lifestyle-related factors. Bonferroni adjustment was applied to account for multiple testing. All statistical analyses were performed with SAS version 9.4 (The SAS Institute, Cary, NC, USA).

3. Results {#sec3-nutrients-11-02842}
==========

Of the 970 mothers enrolled into the Ulm SPATZ Health study, 86% (*n* = 742) mothers were still breastfeeding their infants at 6 weeks. Human milk samples for fatty acid analysis were available from 706 (95.2% of breastfeeding mothers), 483 (87.3% of all breastfeeding mothers), and 83 (52.3% of all breastfeeding mothers) lactating women at 6 weeks, 6 months, and 12 months, respectively. Only 81 mothers provided a human milk sample at all three time points (6 weeks, 6 months, and 12 months). The lactating women were aged 32.7 ± 4.8 years, and the characteristics of those women who provided a human milk sample at any one of the three times points are shown in [Table 1](#nutrients-11-02842-t001){ref-type="table"}.

The total lipid content increased significantly at 6 months (β = 0.199, *p* = 0.029) and 12 months (β = 0.421, *p* \< 0.001) of lactation ([Figure 1](#nutrients-11-02842-f001){ref-type="fig"}). These changes remained significant even after adjusting for education, occupation, parity, gestation period, delivery mode, and maternal age. Results from the Wilcoxon sum rank test showed some significant differences of fatty acid concentrations between 6-week, 6-month, and 12-month samples ([Table 2](#nutrients-11-02842-t002){ref-type="table"}). All MUFAs, BCFAs, and TFAs remained statistically similar during lactation. The constituent sizes of the medium chain fatty acids (MCFAs) lauric acid (C12:0), tridecylic (C13:0), and myristic acid (C14:0), were significantly larger at 6 and 12 months compared to 6 weeks.

Following Bonferroni correction, the n-6 metabolites eicosadienoic (C20:2n-6), dihomo-γ-linolenic acid (DGLA; C20:3n-6) and docosadienoic (C22:2n-6) were statistically lower at 6 months compared to 6 weeks. The n-6 metabolite γ-linolenic acid (GLA; C18:3n-6) was lower at 12 months compared to 6 weeks and 6 months. Dihomo-α-linolenic acid (C20:3n-3) was significantly lower at 6 months, and a decrease of C20:4n-3 at 12 months of lactation was observed.

These differences remained significant when the sample size was restricted to human milk samples measured at 6 weeks and 6 months only (*n* = 467; [Supplemental Table S1](#app1-nutrients-11-02842){ref-type="app"}). Significant differences in the constituent sizes of SFAs, MUFAs, BCFAs, and the essential PUFAs linoleic acid (LA; C18:2n-6), α-linoleic acid (ALA; C18:3n-3), and docosahexaenoic acid (DHA; C22:6n-3) were also observed in this sub-sample.

Compositional biplots obtained from the PCA did not show clear and consistent groupings of fatty acid concentrations of human milk samples collected at 6 weeks and 6 months ([Figure 2](#nutrients-11-02842-f002){ref-type="fig"}A,B). This was also the case for the change between 6 weeks and 6 months ([Figure 2](#nutrients-11-02842-f002){ref-type="fig"}D). Relative positions between fatty acids remained consistent and there were unclear groupings when all 6 weeks (*n* = 706), all 6 months (*n* = 483) samples, and those who provided samples at both time points ("6 months restricted samples" (*n* = 467)) were analyzed ([Supplemental Figure S1](#app1-nutrients-11-02842){ref-type="app"}).

Compositional biplots of 12 months samples showed that all fatty acids could be combined into at least 1 of four groups based on the correlations and sub-compositions defining a high-variance ([Figure 2](#nutrients-11-02842-f002){ref-type="fig"}C). The angles between the individual fatty acids in each sub-compositional group were very small. Despite most of the non-significant changes in individual fatty acid constituents between 6 weeks and 12 months, and 6 months and 12 months ([Table 2](#nutrients-11-02842-t002){ref-type="table"}), the correlations of the changes were quite clear and formed distinct sub-compositions, showing two dimensional patterns ([Figure 2](#nutrients-11-02842-f002){ref-type="fig"}E,F).

In a third PCA and compositional biplots, only 32 fatty acids were included. Inclusion of fatty acid into the PCA was based on the most commonly reported fatty acids in previous studies. The compositional biplots from this PCA showed very clear and more distinct patterns of fatty acid sub-compositions based on their correlational properties ([Supplemental Figure S2](#app1-nutrients-11-02842){ref-type="app"}).

The changes in fatty acid concentrations across time were further evaluated using the fatty acid groups derived from the 12 months compositional biplots as well as the traditional chemical groupings ([Table 3](#nutrients-11-02842-t003){ref-type="table"}). In a crude model, the 12 month-derived fatty acid group 2 was significantly higher at 6 months (β = 0.037, *p* = 0.0046) and 12 months (β = 0.114, *p* = \<0.0001), group 3 was lower at 12 months (β = −0.059, *p* = 0.0013), and group 4 was lower at 6 months (β = 0.086, *p* = 0.0003) of lactation. These changes remained significant even after adjusting for maternal age, education, occupation, parity, gestation period, delivery mode, BMI, and Bonferroni correction ([Table 3](#nutrients-11-02842-t003){ref-type="table"}). While the relative positions and direction of each of the individual fatty acids changed at each time point in the compositional biplots ([Figure 2](#nutrients-11-02842-f002){ref-type="fig"}), the total TFAs, BCFAs, and total PUFAs remained statistically similar at each time point.

4. Discussion {#sec4-nutrients-11-02842}
=============

In the present birth cohort study, we evaluated the changes in fatty acid composition of human milk sampled at 6 weeks, 6 months, and 12 months post-delivery, using statistical methods accounting for compositional data. Firstly, we observed a marked increase in total lipid content of human milk similar to previous studies \[[@B9-nutrients-11-02842],[@B12-nutrients-11-02842],[@B23-nutrients-11-02842],[@B24-nutrients-11-02842]\] and we attribute these changes to the high energy requirements of the growing infant. This increasing proportion of the lipid fraction in human milk provides the infant with adequate energy during the first months of life, when human milk is the sole source of nutrition for the infant. In addition, the average amount of the lipid content in mature milk also changes during the course of a day and increases during an individual feed \[[@B25-nutrients-11-02842]\]. On the other hand, our results show that there were two possible distributions among lactating women whose lipid content was available at 6 weeks. Further analysis showed that this distribution was confounded by obesity thus an indication of possible interindividual and intraindividual variations in the lipid content human milk.

In addition, following clr transformation, we observed that palmitic acid (C16:0) remained the major SFA, and oleic acid (C18:1n-9) constituted the largest part of MUFAs. Nonetheless, based on the correlational attributes of fatty acids, our data do not show exclusive and distinct fatty acids groups that are based on their chain length, degree of saturation, or traditional chemical groupings used in previous studies. The individual fatty acids in the compositional biplots were plotted very close to each other indicating high correlations among them \[[@B26-nutrients-11-02842]\]. Thus, concentrations of fatty acids may not be interpreted independently from each other.

Our results further show that some fatty acids of small constituent sizes are highly variable. The inclusion of these small fatty acids in the analysis of overall composition leads to a shift in balance between fatty acid constituents and to increased variation in other fatty acids of larger constituent size. Similarly to other studies \[[@B16-nutrients-11-02842],[@B22-nutrients-11-02842],[@B27-nutrients-11-02842],[@B28-nutrients-11-02842]\], a second analysis and PCA using only 32 fatty acids that had been used in previous research showed fatty acid groups that were not exclusive to n-3 or n-6 fatty acids ([Supplemental Figure S2](#app1-nutrients-11-02842){ref-type="app"}). We acknowledge that there is no standardized list of fatty acids that has to be included in the "sum of total fatty acids". However, the fewer the fatty acids that are summed, the greater the apparent profile percentage of those reported \[[@B29-nutrients-11-02842]\]. Granted that some of the fatty acids of very small constituent size have a putative impact on the other fatty acids of larger constituent sizes, they could have a crucial role in the pathophysiology of the overall fatty acid composition of human milk.

There were no distinct sub-compositional groups of fatty acids from human milk sampled at 6 weeks and 6 months post-delivery. However, the compositional biplots of human milk collected at 6 months showed some changes in the position and direction of the individual fatty acids compared to the 6 weeks biplots. Although these changes were not striking, they only became clearer at 12 months when all fatty acids could be combined into one of four sub-compositional groups based on their correlational properties. This is a clear indication that the fatty acid profile of human milk during prolonged lactation is not identical to that of human milk during short-term lactation. These changes in human milk fatty acid composition could be reflective of the mother's metabolic adaptation to the changing needs of the growing infant, as well as mammary gland biosynthetic capacity \[[@B30-nutrients-11-02842]\]. However, whether these profiles are independent of the frequency, exclusivity, or type of breastfeeding still remains to be explored.

Amongst the several factors shown to influence human milk fatty acid composition, maternal dietary habits have a short- and long-term impact on human milk fatty acid composition \[[@B31-nutrients-11-02842]\]. Although we do not have dietary data from the lactating mothers, we used the child indicator food index (assessed at ages four and five years) as a remote proxy for maternal diet. A comparatively simple index was calculated based on the consumption of seven food groups \[[@B32-nutrients-11-02842]\] and was used as an indicator of a favorable, neutral, or unfavorable diet. Our results show that more than 50% of the children at ages four and five years, potentially extending to the whole family including the mother, were most likely consuming a favorable diet. In addition, maternal age, higher education, and subsequent lower rates of individual risk factors including obesity were previously found to be closely associated with prolonged breastfeeding \[[@B17-nutrients-11-02842]\]. Therefore, granted that the majority of lactating women were highly educated, of high maternal age, and of presumably high socio-economic status, it is plausible that they were taking some supplements, perhaps even fish oil, which could have driven the PCA results. Thus, we attribute the changes in human milk fatty acid profile at 12 months to an increased stability of the mother's diet as well as other lifestyle changes that are associated with a longer duration of lactation.

We identified a sub-compositional cluster which comprised TFAs from partially hydrogenated vegetable oils (PHVOs; C18:1n-9t), BCFAs (C15:0ai, C16:0i, C18:0i), and the odd chain fatty acids (OCFAs; C15:0, C17:0) found in ruminant fats, from a typical western diet \[[@B33-nutrients-11-02842]\]. TFAs are typically used as biomarkers for dietary intake. Thus this compositional cluster remained unchanged during lactation, suggesting that the secretion of TFAs, BCFAs, and OCFAs remains stable during lactation. In addition, TFAs have been associated with adverse effects with respect to essential fatty acid and long-chain PUFA (LCPUFA) metabolism in humans \[[@B34-nutrients-11-02842]\], oxidative stress, and infant development \[[@B35-nutrients-11-02842]\]. Similar to the previous Ulm birth cohort study \[[@B9-nutrients-11-02842]\] and earlier studies \[[@B36-nutrients-11-02842]\] in which researchers reported inverse correlations between TFAs and various n-3 and n-6 PUFAs, this fatty acid sub-compositional group comprising TFAs had loadings that are in the opposite direction of the n-3/n-6 dominated sub-compositional group.

Furthermore, a second sub-compositional group was characterized by the essential fatty acid ALA, medium-chain SFAs (C10:0-C14:0), and the long-chain SFA palmitic acid (C16:0) that are acquired through endogenous synthesis and dietary intake \[[@B37-nutrients-11-02842]\]. The benefits of individual SFAs in infant nutrition are an eminent topic of interest. Capric acid (C10:0) and lauric acid (C12:0) are linked to antimicrobial biological activities \[[@B38-nutrients-11-02842]\], while myristic acid (C14:0) and palmitic exhibit specific properties for protein acylation \[[@B39-nutrients-11-02842]\]. It is also noteworthy that ALA is an essential fatty acid that can influence metabolic processes and is important for the endogenous synthesis of its respective LCPUFA. Even though some of the individual SFAs and n-3 PUFAs remained statistically unchanged at 6 and 12 months, this sub-compositional group was significantly higher at 6 months and 12 months of lactation. Additionally, the relative positions and direction of these individual fatty acids changed, suggesting proportional response of the mammary gland as the needs of the infants change during lactation. Thus, the physiological and health consequences associated with these compositional changes are not known and would require further exploration.

Moreover, our results showed a significant decrease of the sub-compositional group which predominantly comprised long-chain n-3 and n-6 fatty acids at 12 months. These results are in contrast to other studies that found marked increases in concentrations of DHA in human milk at 6 months \[[@B9-nutrients-11-02842]\] and 9 months \[[@B24-nutrients-11-02842]\]. Also, while stearic acid (C18:0) and oleic acid (C18:1n-9) formed part of this sub-compositional group, their importance in infants have not yet been explored in detail in spite of their abundance and regulation within the mammary gland during fat synthesis and lactation. Arachidonic acid (AA, C20:4n-6) and adrenic acid (C22:4n-6) formed a sub-compositional group which was further characterized by long-chain SFAs (C19:0-C24:0) and MUFAs including nervonic acid (C24:1n-9) and docosapentaenoic acid (C22:5n-3). Although this sub-compositional group remained statistically unchanged throughout lactation, MUFAs are the second most common proportion in human milk, but their nutritional relevance and potential functionalities have not been explored in infants \[[@B40-nutrients-11-02842]\]. A potentially important aspect about the conversion on AA in vivo is that it functions an immediate precursor of adrenic acid \[[@B41-nutrients-11-02842]\]. However, just like AA, rapid accretion of adrenic acid occurs during the early postnatal period on the brain growth spurt in infants. Thus this particular combination of essential and non-essential fatty acids is of strong interest and requires further clinical or population-based investigations to identify and better understand the pathophysiology of these fatty acids. Nonetheless, both mammary gland activity such as de novo lipogenesis and the digestion have a considerable effect on the human milk fatty acid profile.

A limitation of this study is the lack of direct dietary data and potential for selection bias thus the data cannot be used to generalize information regarding all lactating women. Thus, the observational nature of this study restricts the possibility of drawing conclusions on causation, particularly between fatty acid profile, diet and socio-economic status. However, a strength of this study is the human milk samples available at three times points of lactation. Our findings support the hypothesis that a combination of multiple fatty acids is important in fatty acid profiling beyond the presentation of individual fatty acids. Thus, selecting a statistically appropriate balance may help to avoid spurious results and better address the biological mechanisms associated with the changes in human milk fatty acid composition. It is also important to consider the high variability of small fatty acids and this should be awarded attention because a compositional analysis may lead to more pronounced changes in the human milk fatty acid profile. Although exploring human milk fatty acid compositions using a more standard approach like chemical-based groupings could be methodologically constant, this may not be robust enough.

5. Conclusions {#sec5-nutrients-11-02842}
==============

In conclusion, the fatty acid composition of human milk sampled at 6 weeks, 6 months, and 12 months may not group in similar sub-compositional patterns. Thus, the composition of human milk during prolonged lactation is different from the composition of human milk during short duration of lactation. However, whether these changes are associated with specific improved developmental or health outcomes in infants still remains to be studied. We recommend further clinical or population-based investigations to identify and better understand the pathophysiology of the different sub-compositional fatty acids groups in human milk during lactation.
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###### 

Characteristics of the lactating women included in the Ulmer SPATZ Health study.

  Characteristic                                          All 6 Weeks Samples (*n* = 706)   All 6 Months Samples (*n* = 483)   All 12 Months Samples (*n* = 83)                
  ------------------------------------------------------- --------------------------------- ---------------------------------- ---------------------------------- ------- ---- -------
  Age                                                     706                               33.1                               483                                33.5    83   34.4
  Gestation period                                                                                                                                                             
  Early (37 or 38 weeks)                                  146                               22.5%                              96                                 21.5%   18   22.8%
  Full (39 or 40 weeks)                                   397                               61.3%                              275                                61.5%   47   59.5%
  Late or Post (41 or 42 weeks)                           105                               16.2%                              76                                 17.0%   14   17.7%
  Parity (*n* births of fetus ≥24 weeks)                                                                                                                                       
  0 births                                                368                               52.2%                              252                                52.2%   39   47.0%
  ≥1 birth                                                337                               47.8%                              231                                47.8%   44   53.0%
  Delivery mode                                                                                                                                                                
  Vaginal spontaneous                                     480                               68.1%                              344                                71.2%   60   72.3%
  Elective caesarean                                      69                                9.8%                               39                                 8.1%    9    10.8%
  Emergency caesarean                                     90                                12.8%                              56                                 11.6%   9    10.8%
  Vaginal assisted                                        66                                9.4%                               44                                 9.1%    5    6.0%
  Maternal pre-pregnancy body mass index (BMI) category                                                                                                                        
  Underweight (BMI \< 18.50)                              12                                1.8%                               6                                  1.3%    3    3.8%
  Normal (18.50 ≤ BMI \< 25.00)                           443                               64.8%                              325                                69.3%   55   68.8%
  Overweight (25.00 ≤ BMI \< 30.00)                       150                               21.9%                              93                                 19.8%   15   18.8%
  Obese (BMI \> 30.00)                                    79                                11.5%                              45                                 9.6%    7    8.8%
  Maternal BMI category (6 weeks)                                                                                                                                              
  Underweight                                             6                                 1.0%                               3                                  0.7%         
  Normal                                                  364                               58.0%                              268                                60.4%   45   56.3%
  Overweight                                              189                               30.1%                              131                                29.5%   27   33.8%
  Obese                                                   69                                11.0%                              42                                 9.5%    8    10.0%
  Maternal BMI category (6 months)                                                                                                                                             
  Underweight                                             15                                2.6%                               10                                 2.4%    3    3.9%
  Normal                                                  360                               62.8%                              277                                66.4%   50   64.9%
  Overweight                                              136                               23.7%                              92                                 22.1%   18   23.4%
  Obese                                                   62                                10.8%                              38                                 9.1%    6    7.8%
  Education level                                                                                                                                                              
  Low                                                     43                                6.2%                               16                                 3.4%    3    3.7%
  Intermediate                                            196                               28.2%                              115                                24.2%   13   16.0%
  High                                                    455                               65.6%                              345                                72.5%   65   80.2%
  Occupation                                                                                                                                                                   
  Leadership/professionals                                148                               30.3%                              102                                30.2%   20   34.5%
  Intermediate position                                   223                               45.6%                              160                                47.3%   27   46.6%
  Skilled manuals/non-manuals                             88                                18.0%                              63                                 18.6%   8    13.8%
  Unskilled/semi-skilled                                  18                                3.7%                               5                                  1.5%    1    1.7%
  Self-employed                                           12                                2.5%                               8                                  2.4%    2    3.4%
  Indicator food index (child, age 4)                                                                                                                                          
  Neutral                                                 221                               44.2%                              153                                40.7%   28   38.9%
  Favorable                                               279                               55.8%                              223                                59.3%   44   61.1%
  Indicator food index (child, age 5)                                                                                                                                          
  Neutral                                                 198                               45.3%                              150                                44.9%   29   43.9%
  Favorable                                               237                               54.2%                              182                                54.5%   37   56.1%
  Unfavorable                                             2                                 0.5%                               2                                  0.6%         
  Maternal alcohol consumption                                                                                                                                                 
  Never drinker                                           165                               23.4%                              114                                23.6%   40   48.2%
  Abstinent drinker                                       203                               28.8%                              173                                35.8%   24   28.9%
  Resumed drinking at 6 weeks to 6 months                 150                               21.2%                              90                                 18.6%   8    9.6%
  Resumed drinking by 6 weeks                             115                               16.3%                              73                                 15.1%   10   12.0%
  Undetermined drinking                                   73                                10.3%                              33                                 6.8%    1    1.2%
  Smoking relapse status by 2 years                                                                                                                                            
  Non-smoker                                              539                               78.3%                              394                                82.8%   74   89.2%
  Relapse by 6 weeks                                      48                                7.0%                               16                                 3.4%    2    2.4%
  Relapse by 6 months                                     22                                3.2%                               7                                  1.5%         
  Relapse 6 months to 2 years                             27                                3.9%                               18                                 3.8%         
  Abstained up to 2 years                                 52                                7.6%                               41                                 8.6%    7    8.4%

Sums (*n*) may not always add up to total because of missing data for certain items. Percentages exclude missing data.
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###### 

Means and standard deviations of centered log ratio (clr)-transformed fatty acid concentrations of human milk samples measured at 6 weeks, 6 months, and 12 months of lactation (*n* = 81).

  Fatty Acid      Common Name           6 Weeks   6 Months   12 Months   *p* Value ^a^   *p* Value ^b^   *p* Value ^c^                       
  --------------- --------------------- --------- ---------- ----------- --------------- --------------- --------------- --------- --------- ---------
  C8:0            Caprylic              −0.07     (0.57)     0.06        (0.47)          0.01            (0.47)          0.2109    0.3500    0.7188
  C10:0           Capric                2.03      (0.26)     2.09        (0.22)          2.10            (0.25)          0.1135    0.9546    0.1166
  C11:0           Undecylic             −2.25     (0.33)     −2.21       (0.34)          −2.28           (0.34)          0.3313    0.1943    0.6914
  C12:0           Lauric                3.25      (0.36)     3.42        (0.31)          3.67            (0.29)          0.0021    \<.0001   \<.0001
  C13:0           Tridecylic            −1.61     (0.24)     −1.55       (0.42)          −1.50           (0.59)          0.0125    0.0357    \<.0001
  C14:0           Myristic              3.50      (0.23)     3.68        (0.20)          3.98            (0.26)          \<.0001   \<.0001   \<.0001
  C15:0           Pentadecylic          0.80      (0.25)     0.86        (0.26)          0.82            (0.25)          0.1090    0.4683    0.3561
  C16:0           Palmitic              4.88      (0.15)     4.90        (0.14)          4.91            (0.15)          0.6024    0.3884    0.1903
  C17:0           Margaric              0.61      (0.17)     0.64        (0.17)          0.65            (0.16)          0.1620    0.6212    0.0366
  C18:0           Stearic               3.69      (0.21)     3.72        (0.21)          3.72            (0.18)          0.4243    0.8974    0.3372
  C19:0           Nonadecylic acid      −1.84     (0.27)     −1.80       (0.26)          −1.77           (0.21)          0.1869    0.9213    0.1300
  C20:0           Arachidic             0.16      (0.21)     0.14        (0.21)          0.16            (0.23)          0.4986    0.6791    0.7771
  C22:0           Behenic               −0.68     (0.26)     −0.70       (0.24)          −0.64           (0.34)          0.5421    0.5839    0.9626
  C23:0           Tricosylic            −3.93     (1.99)     −3.36       (1.63)          −3.63           (1.94)          0.0489    0.3875    0.2778
  C24:0           Lignoceric            −1.16     (0.51)     −1.18       (0.46)          −1.05           (0.47)          0.5388    0.0927    0.2675
  C12:1n-1                              −2.23     (0.34)     −2.18       (0.35)          −2.20           (0.38)          0.4302    0.8789    0.5050
  C14:1n-5        Myristoleic           0.48      (0.28)     0.53        (0.33)          0.45            (0.33)          0.3022    0.1776    0.7063
  C16:1n-7        Palmitoleic           2.55      (0.32)     2.50        (0.27)          2.46            (0.26)          0.2975    0.2921    0.0640
  C18:1n-7        Vaccenic              2.19      (0.24)     2.15        (0.19)          2.14            (0.21)          0.0966    0.8250    0.0842
  C18:1n-9        Oleic                 5.26      (0.20)     5.29        (0.16)          5.25            (0.19)          0.4828    0.1189    0.4663
  C20:1n-9        Eicosenoic            0.86      (0.24)     0.76        (0.23)          0.80            (0.26)          0.0035    0.3658    0.0366
  C22:1n-9        Erucic                −0.89     (0.29)     −1.02       (0.29)          −0.90           (0.32)          0.0057    0.0133    0.6572
  C24:1n-9        Nervonic              −1.62     (0.95)     −1.60       (0.57)          −1.38           (0.56)          0.2704    0.0202    0.3101
  C15:0 anteiso   Anteisopentadecylic   −0.44     (0.37)     −0.33       (0.40)          −0.38           (0.45)          0.0221    0.5656    0.0845
  C16:0 iso       Isopalmitic           −0.72     (0.31)     −0.64       (0.33)          −0.69           (0.34)          0.0728    0.3149    0.3330
  C18:0 iso                             −1.89     (0.24)     −1.86       (0.23)          −1.84           (0.24)          0.1615    0.8329    0.1142
  C14:1n-5t       Myristelaidic         −4.26     (0.56)     −4.20       (0.51)          −4.25           (0.67)          0.3483    0.3893    0.9213
  C15:1n-5t                             −4.23     (0.71)     −4.14       (0.48)          −4.19           (0.74)          0.5931    0.8921    0.5851
  C16:1n-7t                             −1.58     (0.34)     −1.58       (0.35)          −1.60           (0.38)          0.6177    0.9027    0.7263
  C18:1n-9t       Elaidic               0.89      (0.54)     1.01        (0.62)          1.04            (0.54)          0.0966    0.9439    0.0386
  C18:2n-6tt      Linolelaidic          −0.90     (0.67)     −0.73       (0.50)          −0.97           (0.88)          0.0155    0.0510    0.5908
  C18:2n-6        Linoleic              4.03      (0.30)     4.08        (0.33)          4.06            (0.33)          0.4612    0.6236    0.8525
  C18:3n-6        γ-linolenic           −0.42     (0.39)     -0.61       (0.37)          −0.93           (0.44)          0.0029    \<.0001   \<.0001
  C20:2n-6        Eicosadienoic         0.36      (0.26)     0.19        (0.28)          0.24            (0.29)          \<.0001   0.1177    0.0017
  C20:3n-6        Dihomo-γ-linolenic    0.66      (0.27)     0.38        (0.26)          0.31            (0.29)          \<.0001   0.1131    \<.0001
  C20:4n-6        Arachidonic           0.80      (0.27)     0.75        (0.24)          0.79            (0.28)          0.1954    0.3847    0.6236
  C22:2n-6        Docosadienoic         −2.13     (0.95)     −2.50       (1.12)          −2.30           (0.93)          \<.0001   0.0667    0.0149
  C22:4n-6        Adrenic               −0.97     (0.65)     −0.99       (0.29)          −0.85           (0.41)          0.0857    0.0014    0.1321
  C22:5n-6        Osbond                −1.62     (0.54)     −1.71       (0.35)          −1.74           (0.48)          0.0122    0.4954    0.0464
  C18:3n-3        α -linoleic           1.59      (0.40)     1.67        (0.42)          1.56            (0.36)          0.2960    0.1237    0.7630
  C20:3n-3        Dihomo-α-linoleic     −1.54     (0.49)     −1.71       (0.33)          −1.65           (0.32)          0.0002    0.3684    0.0038
  C20:4n-3                              −0.74     (0.37)     −1.10       (0.35)          −1.32           (0.43)          \<.0001   0.0008    \<.0001
  C20:5n-3        Eicosapentaenoic      −1.01     (0.35)     −1.03       (0.43)          −1.19           (0.39)          0.6142    0.0194    0.0021
  C22:5n-3        Docosapentanoic       −0.17     (0.23)     −0.16       (0.21)          −0.06           (0.20)          0.7887    0.0030    0.0027
  C22:6n-3        Docosahexaenoic       0.30      (0.44)     0.12        (0.52)          0.20            (0.43)          0.0073    0.2025    0.1004

*p* Values derived from Wilcoxon signed-rank test comparing fatty acid concentrations measured at ^a^ 6 weeks and 6 months, ^b^ 6 months and 12 months, and ^c^ 6 weeks and 12 months. Bonferroni-adjusted level of statistical significance is α = 0.05/45 = 0.0011.
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###### 

Changes in human milk fatty acid composition during the first year of lactation.

  Fatty Acid              6 Weeks (*n* = 81)   6 Months (*n* = 81)   12 Months (*n* = 81)                      
  ----------------------- -------------------- --------------------- ---------------------- --------- -------- ----------
  **12 Months Derived**                                                                                        
  Group 1                 1.4                  (1.4, 1.4)            0.037                  0.4470    −0.011   0.8028
  Group 2                 −1.5                 (−1.6, −1.5)          0.049                  0.0062    0.122    \<0.0001
  Group 3                 1.8                  (1.8, 1.9)            −0.007                 0.7908    −0.067   0.0029
  Group 4                 −1.7                 (−1.8, −1.7)          −0.079                 0.0073    −0.044   0.0998
  SFA                     2.3                  (2.4, 2.4)            0.038                  0.1476    0.105    \<0.0001
  MUFA                    2.3                  (2.2, 2.3)            −0.021                 0.4191    −0.080   0.0012
  Trans-FA                −2                   (−2.1, −1.8)          0.073                  0.4245    0.090    0.2813
  BCFAs                   −2.9                 (−3.0, −2.8)          0.041                  0.5426    −0.039   0.5039
  PUFA                    1.2                  (1.1, 1.2)            0.017                  0.6632    −0.034   0.2977
  ∑n-3 PUFA               −1                   (−1.1, −0.9)          −0.035                 0.4612    −0.111   0.0125
  ∑n-3 LCPUFA             −1.9                 (−2.0, −1.8)          −0.158                 0.0003    −0.160   \<0.0001
  ∑n-6 PUFA               1                    (1.0, 1.1)            0.024                  0.5694    −0.022   0.5128
  ∑n-6 LCPUFA             −1.2                 (−1.3, −1.2)          −0.178                 \<.0001   −0.171   \<0.0001

^a^ Least Square Means (95% Confidence Limits). 12 months: Group 1 (C18:0i, C16:0i, C15:0ai, C16:1n-7t, C18:1n-9t, C18:2n-6tt, C14:1n-5t, C12:1n-1, C14:1n-5, C15:0, C17:0); Group 2 (C10:0, C11:0, C12:0, C13:0, C14:0, C16:0, C15:1n-5t, C18:3n-3); Group 3 (C20:5n-3, C22:6n-3, C20:4n-3, C20:3n-6, C8:0, C18:3n-6, C18:2n-6, C18:0, C22:5n-6, C18:1n-7, C22:2n-6, C20:3n-6, C20:2n-6, C18:1n-9); Group 4 (C19:0, C20:0, C22:0, C23:0, C24:0, C20:1n-9, C24:1n-9, C22:1n-9, C22:5n-3, C22:4n-6, C20:4n-6). SFA: saturated fatty acid; MUFA: monounsaturated fatty acid; Trans-FA: trans-fatty acid; BCFA: branched chain fatty acid; PUFA: polyunsaturated fatty acid; LCPUFA: Long-chain polyunsaturated fatty acid; Maternal age, education, occupation, parity, pre-pregnancy BMI, and delivery mode were added as covariates. Bonferroni adjusted level of statistical significance: α = 0.05/4 = 0.0125.
